NASDAQ:CGC

Canopy Growth Price Target, Predictions & Analyst Ratings

$14.83
+0.04 (+0.27 %)
(As of 09/16/2021 04:00 PM ET)
Add
Compare
Today's Range
$14.65
$15.05
50-Day Range
$14.63
$22.23
52-Week Range
$13.83
$56.50
Volume2.69 million shs
Average Volume4.56 million shs
Market Capitalization$5.83 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.05

Canopy Growth (NASDAQ:CGC) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analyst Rating Consensus

Hold
Based on 14 Analyst Ratings

Analyst Price Target Consensus

$31.34

High PT$55.00
Average PT$31.34
Low PT$21.10
TypeCurrent
9/17/20 to 9/17/21
1 Month Ago
8/18/20 to 8/18/21
3 Months Ago
6/19/20 to 6/19/21
1 Year Ago
9/18/19 to 9/17/20
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
Hold
10 Hold rating(s)
11 Hold rating(s)
10 Hold rating(s)
13 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
2 Sell rating(s)
3 Sell rating(s)
Consensus Price Target$31.34$31.34$32.90$28.69
Price Target Upside111.36% Upside21.35% Upside4.17% Upside56.84% Upside
Get Canopy Growth Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter.


Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Canopy Growth (NASDAQ:CGC) vs. Its Competitors

TypeCanopy GrowthMedical CompaniesS&P 500
Consensus Rating Score
2.14
2.73
2.56
Consensus RatingHoldBuyBuy
Price Target Upside124.64% Upside7.43% Upside
News Sentiment RatingPositive News
Neutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
14
42.42%
Underperform Votes
19
57.58%
Avg. Outperform Votes
178
67.17%
Avg. Underperform Votes
87
32.83%
Avg. Outperform Votes
829
69.55%
Avg. Underperform Votes
363
30.45%

Canopy Growth (NASDAQ:CGC) Analyst Ratings History

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/11/2021Jefferies Financial Group
UpgradeUnderperform ➝ Hold
8/9/2021CIBC
Lower Price TargetNeutralC$30.00 ➝ C$27.00+43.46%
8/9/2021Canaccord Genuity
Boost Price TargetHoldC$25.00 ➝ C$30.00+56.66%
7/8/2021Piper Sandler
Lower Price TargetNeutral$27.00 ➝ $24.00+8.11%
6/3/2021Desjardins
Lower Price TargetHoldC$55.00 ➝ C$35.00+31.28%
6/2/2021Eight Capital
UpgradeSell ➝ Neutral
6/1/2021Alliance Global Partners
Reiterated RatingNeutral$40.00 ➝ $32.00+31.80%
5/25/2021MKM Partners
UpgradeNeutral ➝ Buy$55.00+142.50%
4/28/2021Bank of America
Initiated CoverageBuy
4/9/2021Cantor Fitzgerald
Lower Price TargetNeutral$62.00 ➝ $35.00+22.81%
2/10/2021Cormark
DowngradeMarket Perform ➝ Reduce
2/10/2021BMO Capital Markets
Reiterated RatingMarket Perform
2/10/2021Benchmark
DowngradeBuy ➝ Hold
2/4/2021Stifel Nicolaus
Reiterated RatingBuy$23.00-48.82%
9/4/2020Cfra
UpgradeBuy ➝ Strong-Buy
8/21/2020Oppenheimer
Rupesh Parikh
Reiterated RatingHold
6/1/2020Scotiabank
Boost Price TargetSector Perform$28.00 ➝ $33.00+99.76%
6/1/2020LADENBURG THALM/SH SH
DowngradeBuy ➝ Neutral
6/1/2020Pi Financial
J. Zandberg
DowngradeNeutral ➝ Sell
6/1/2020Bryan, Garnier & Co
DowngradeNeutral ➝ Sell
3/5/2020Laurentian Bank of Canada
Chris Blake
UpgradeBuy
11/15/2019Compass Point
Lower Price TargetNeutral$24.00 ➝ $17.00+7.32%
10/22/2019Piper Jaffray Companies
Michael Lavery
Lower Price TargetOverweight$40.00 ➝ $36.00+76.90%
10/14/2019Seaport Global Securities
B. Hundley
DowngradeBuy ➝ Neutral
6/28/2019Consumer Edge
Initiated CoverageEqual Weight ➝ Equal Weight
6/12/2019Evercore ISI
Initiated CoverageOutperform$120.00 ➝ $107.57+150.45%
4/22/2019GMP Securities
UpgradeHold ➝ Buy$65.00 ➝ $72.00+61.58%
(Data available from 9/17/2016 forward. View 10+ years of historical ratings with our analyst ratings screener.)
speech bubbles
speech bubbles











Canopy Growth (NASDAQ:CGC) Analyst Ratings Frequently Asked Questions

What is Canopy Growth's consensus rating and price target?

According to the issued ratings of 14 analysts in the last year, the consensus rating for Canopy Growth stock is Hold based on the current 1 sell rating, 10 hold ratings and 3 buy ratings for CGC. The average twelve-month price target for Canopy Growth is $31.34 with a high price target of $55.00 and a low price target of $21.10. Learn more on CGC's analyst rating history

Do Wall Street analysts like Canopy Growth more than its competitors?

Analysts like Canopy Growth stock less than the stock of other Medical companies. The consensus rating for Canopy Growth is Hold while the average consensus rating for medical companies is Buy. Learn more on how CGC compares to other companies

Do MarketBeat users like Canopy Growth more than its competitors?

MarketBeat users like Canopy Growth stock less than the stock of other Medical companies. 42.42% of MarketBeat users gave Canopy Growth an outperform vote while medical companies recieve an average of 67.17% outperform votes by MarketBeat users.

Is Canopy Growth being upgraded by Wall Street analysts?

Over the previous 90 days, Canopy Growth's stock had 1 upgrade by analysts.

Does Canopy Growth's stock price have much upside?

According to analysts, Canopy Growth's stock has a predicted upside of 21.35% based on their 12-month price targets.

What analysts cover Canopy Growth?

Canopy Growth has been rated by Canaccord Genuity, CIBC, Jefferies Financial Group, and Piper Sandler in the past 90 days.

This page was last updated on 9/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.